Loading your page…

Marketing-authorisation holder · Latvia

Kalceks As

Latvia128 medicines6 countries

128 medicines in 6 countries, as authorisation holder, manufacturer and marketer.

Medicines

Every medicine in the registers under its name, current ones first.

1–25 of 128

Medicine	Substance	Country	Status	Authorised
Alfentanil Kalceks 0,5 mg/ml oplossing voor injectie/infusieOplossing voor injectie of infusie	Alfentanil	Netherlands	Authorised	2019
Atracurium Kalceks 10 mg/ml oplossing voor injectie/infusieOplossing voor injectie of infusie	Atracurium	Netherlands	Authorised	2017
BUTILESCOPOLAMINA KALCEKS 20 MG/ML SOLUCION INYECTABLE EFG20 mg · Solución inyectable	Butilescopolamina	Spain	Marketed	2021
Ceftriakson Kalceks 1 g prašak za otopinu za injekciju/infuziju*Prašak za otopinu za injekciju / infuziju	Ceftriaxone	Croatia	Not marketed	2023
Ceftriakson Kalceks 2 g prašak za otopinu za injekciju/infuziju*Prašak za otopinu za injekciju / infuziju	Ceftriaxone	Croatia	Not marketed	2023
Ceftriaxon Kalceks 1 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie	Ceftriaxone	Netherlands	Authorised	2022
Ceftriaxon Kalceks 2 g poeder voor oplossing voor injectie/infusiePoeder voor oplossing voor injectie of infusie	Ceftriaxone	Netherlands	Authorised	2022
CEFTRIAXONE KALCEKSPolvere per soluzione iniettabile/per infusione	Ceftriaxone	Italy	Authorised
CISATRACURIO KALCEKSSoluzione iniettabile o per infusione	Cisatracurium	Italy	Authorised
CISATRACURIO KALCEKS 2 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG2,68 mg/ml · Solución inyectable y para perfusión	Cisatracurium	Spain	Marketed	2021
CLINDAMICINA KALCEKSSoluzione iniettabile o per infusione	Clindamycin	Italy	Authorised
CLINDAMICINA KALCEKS 150 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG178,2 mg/ml · Solución inyectable y para perfusión	Clindamycin	Spain	Marketed	2024
Clindamycine Kalceks 150 mg/ml oplossing voor injectie/infusieOplossing voor injectie of infusie	Clindamycin	Netherlands	Authorised	2024
Deksametazon Kalceks 4 mg/ml otopina za injekciju/infuzijuOtopina za injekciju / infuziju	Dexamethasone	Croatia	Marketed	2021
Deksmedetomidin Kalceks 100 mikrograma/ml koncentrat za otopinu za infuzijukoncentrat za otopinu za infuziju	Dexmedetomidine	Croatia	Not marketed	2024
DESAMETASONE KALCEKSSoluzione iniettabile o per infusione	Desametasone	Italy	Authorised
DEXAMETASONA KALCEKS 4 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG4,37 mg · Solución inyectable y para perfusión	Dexamethasone	Spain	Marketed	2021
Dexamethasonfosfaat Kalceks 4 mg/ml oplossing voor injectie/infusieOplossing voor injectie of infusie	Dexamethasone	Netherlands	Authorised	2021
DEXMEDETOMIDINA KALCEKSConcentrato per soluzione per infusione	Dexmedetomidine	Italy	Authorised
DEXMEDETOMIDINA KALCEKS 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG0,236 mg · Concentrado para solución para perfusión	Dexmedetomidine	Spain	Marketed	2020
Dexmedetomidine Kalceks 100 microgram/ml concentraat voor oplossing voor infusieConcentraat voor oplossing voor infusie	Dexmedetomidine	Netherlands	Authorised	2019
Droperidol Kalceks 1,25 mg/ml oplossing voor injectieOplossing voor injectie	Droperidol	Netherlands	Authorised	2021
Droperidol Kalceks 2,5 mg/ml oplossing voor injectieOplossing voor injectie	Droperidol	Netherlands	Authorised	2021
DROPERIDOL KALCEKS 2,5 MG/ML SOLUCION INYECTABLE EFG2,5 mg/ml · Solución inyectable	Droperidol	Spain	Marketed	2021
DROPERIDOLO KALCEKSSoluzione iniettabile	Droperidol	Italy	Authorised

Sources and licences

Country	Medicines	Current	Past	Companies
Netherlands	42	42	0	Companies All medicines
Spain	33	15	18	Companies All medicines
Croatia	24	24	0	Companies All medicines
Italy	19	19	0	Companies All medicines
Romania	8	0	8	Companies All medicines
Canada	2	2	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 16 sources

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Ministerul Sănătății

Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

ALIMS

ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.

Licence: Serbian Open Data Licence (sodl)

Report an error or request removalCorrections from the company itself are welcome.

Kalceks As

Medicines

Know your medicines, with the sources.

Kalceks As

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Latvia: more companies